PhRMA urges USTR to protect US innovation abroad

The Pharmaceutical Research and Manufacturers of America (PhRMA) has urged the US Trade Representative (USTR) to protect US innovators abroad.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

USTR report criticises pharma policies in Japan, NZ, Turkey

28 April 2022 US pharmaceutical and medical device industries have expressed concerns regarding the policies of several countries, according to the Office of the US Trade Representatives.

Americas

WHO and UN actions undermine IP and hurt innovation, warns PhRMA

18 March 2019 Supranational organisations such as the World Health Organization and the United Nations Development Program are promoting acts, policies and practices that prevent biopharmaceutical innovators from securing and maintaining patents.

Americas

PhRMA shames Brazil and Thailand over patent backlogs

6 November 2018 Pharmaceutical Research and Manufacturers of America has identified Brazil and Thailand as two of the worst countries for patent delays, in a submission made to a US government report.

More features

The Quintara decision: Defining trade secrets in federal cases

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

PhRMA urges USTR to protect US innovation abroad

More on this story

Editor's picks

Editor's picks

More features